[Antibiotic N',N''-dibenzyleremomycin with reduced 1,2-peptide bond]

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Microbiology

Context:

• Eremomycin, a glycopeptide antibiotic, targets bacterial cell wall synthesis.
• Understanding structure-activity relationships is key to developing novel antibiotics.
• The heptapeptide moiety of eremomycin plays a role in its antibacterial mechanism.

Purpose:

• To synthesize novel eremomycin derivatives with modified amino groups and the first amino acid residue.
• To investigate the role of the peptide bond between the first and second amino acid residues in antibacterial activity.
• To evaluate the impact of structural modifications on eremomycin's interaction with bacterial peptidoglycan precursors.

Summary:

• Novel eremomycin derivatives were synthesized by modifying the eremosamine residues and substituting the N-methyl-D-Leu residue.
• Antibacterial activity was compared for N",N"-dibenzyleremomycin, de-(N-methyl-D-Leu)-N",N"-dibenzyleremomycin, and its N-(2-amino-4-methylpentyl) derivative.
• Cleavage or replacement of the first amino acid residue significantly decreased antibacterial activity against both vancomycin-sensitive and resistant strains.

Impact:

• The findings highlight the critical importance of the first amino acid residue and its peptide linkage for eremomycin's antibacterial potency.
• This research provides insights into the structure-activity relationship of glycopeptide antibiotics.
• The study contributes to the rational design of new antibiotics to combat resistant bacterial infections.